These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11767095)

  • 21. Synthesis and antibacterial activity of new carbapenems containing isoxazole moiety.
    Kang YK; Shin KJ; Yoo KH; Seo KJ; Hong CY; Lee CS; Park SY; Kim DJ; Park SW
    Bioorg Med Chem Lett; 2000 Jan; 10(2):95-9. PubMed ID: 10673088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel lbeta-methylcarbapenems having cyclic sulfonamide moieties: synthesis and evaluation of in-vitro biological activity - part II.
    Kim SJ; Cho JH; Oh CH
    Arch Pharm (Weinheim); 2009 Sep; 342(9):528-32. PubMed ID: 19598286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological properties of new 1beta-methylcarbapenems having tetrazolothioether moiety.
    Shin KJ; Koo KD; Yoo KH; Kim DC; Kim DJ; Park SW
    Bioorg Med Chem Lett; 2000 Jul; 10(13):1421-5. PubMed ID: 10888323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antibacterial evaluation of 1beta-methyl-2-[5-(1-methoxyimino-2-substituted sulfonamide ethyl)pyrrolidin-3-ylthio]carbapenems and their related compounds.
    Jeon H; Jo NH; Yoo KH; Choi JH; Cho H; Cho JH; Oh CH
    Eur J Med Chem; 2007 Mar; 42(3):358-64. PubMed ID: 17156896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted oxadiazolo pyrrolidin-3-yl-thio)carbapenem derivatives.
    Oh CH; Dong HG; Lee JS; Lee SC; Hong JH; Cho JH
    Arch Pharm (Weinheim); 2003 Dec; 336(12):567-72. PubMed ID: 14677150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and structure-activity relationships of 1beta-methylcarbapenems with quaternary ammonium side chains.
    Ishikawa K; Kojima K; Miyauchi M; Endo R; Yasuda H; Kawamoto I
    J Antibiot (Tokyo); 1998 Aug; 51(8):757-70. PubMed ID: 9766468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure-activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety.
    Kawamoto I; Shimoji Y; Kanno O; Kojima K; Ishikawa K; Matsuyama E; Ashida Y; Shibayama T; Fukuoka T; Ohya S
    J Antibiot (Tokyo); 2003 Jun; 56(6):565-79. PubMed ID: 12931867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1 beta-methylcarbapenems.
    Iso Y; Irie T; Nishino Y; Motokawa K; Nishitani Y
    J Antibiot (Tokyo); 1996 Feb; 49(2):199-209. PubMed ID: 8621362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New 1 beta-methylcarbapenems having a hydantoin moiety.
    Oh CH; Kim HJ; Hong SY; Lee YH; Cho JK; Cho JH
    Arch Pharm (Weinheim); 1995 Apr; 328(4):385-7. PubMed ID: 7611834
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis and antibacterial activity of novel 1beta-methyl carbapenems with cycloalkylamine moiety at the C-2 position.
    Kawamoto I; Shimoji Y; Kanno O; Endo R; Miyauchi M; Kojima K; Ishikawa K; Morimoto M; Ohya S
    J Antibiot (Tokyo); 2001 Dec; 54(12):1080-92. PubMed ID: 11858664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antibacterial activity of 1beta-methyl-2-[5-(1,2-disubstituted ethyl)pyrrolidin-3-ylthio]carbapenem derivatives.
    Ahn SH; Jeon H; Choi JH; Baek D; Seo SH; Cho JH; Oh CH
    Arch Pharm (Weinheim); 2006 Feb; 339(2):67-73. PubMed ID: 16429454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic studies of carbapenem and penem antibiotics. III. A synthesis of a key intermediate for 1 beta-methylcarbapenem.
    Sasaki A; Matsumura H; Yano T; Takata S; Sunagawa M
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1098-104. PubMed ID: 1394626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 1: J-111,347 and related compounds.
    Imamura H; Ohtake N; Shimizu A; Jona H; Sato H; Nagano R; Ushijima R; Yamada K; Hashizume T; Morishima H
    Bioorg Med Chem Lett; 2000 Jan; 10(2):109-13. PubMed ID: 10673091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of novel 1 beta-methylcarbapenems with isothiazoloethenyl side chains.
    Kang YK; Lee KS; Yoo KH; Shin KJ; Kim DC; Lee CS; Kong JY; Kim DJ
    Bioorg Med Chem Lett; 2003 Feb; 13(3):463-6. PubMed ID: 12565951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syntheses of 1beta-methylcarbapenems bearing 5-methyl-4-hydroxypyrrolidinone.
    Pyun DK; Kim BJ; Jung HJ; Kim JH; Lee JS; Lee WK; Lee CH
    Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):415-8. PubMed ID: 11911211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antibacterial activity of 1 beta-methylcarbapenem having a 1,3-diazabicyclo[3.3.0]octan-4-one moiety, Part II.
    Oh CH; Lee SC; Park SJ; Lee IK; Nam KH; Lee KS; Chung BY; Cho JH
    Arch Pharm (Weinheim); 1999 Apr; 332(4):111-4. PubMed ID: 10327883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel 1beta-methylcarbapenem, J-111,225: effects of the C-3 and C-5 stereochemistry of the pyrrolidinylthio side chain on antibacterial activities.
    Imamura H; Shimizu A; Sato H; Sugimoto Y; Sakuraba S; Nagano R; Yamada K; Hashizume T; Morishima H
    J Antibiot (Tokyo); 2000 Mar; 53(3):314-6. PubMed ID: 10819306
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
    Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
    Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity.
    Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Shitara E; Iwamatsu K; Atsumi K
    Bioorg Med Chem Lett; 2009 Jan; 19(2):447-50. PubMed ID: 19056265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships of penem antibiotics: crystallographic structures and implications for their antimicrobial activities.
    Tanaka R; Oyama Y; Imajo S; Matsuki S; Ishiguro M
    Bioorg Med Chem; 1997 Jul; 5(7):1389-99. PubMed ID: 9377099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.